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1607-551X/Copyright ª 2015, KaohsiuAbstract Vitamin D and its derivatives have modulatory effects in immunological and inflam-
matory responses. Such properties suggest that they might have an impact on chronic inflam-
matory airway diseases, including nasal polyposis. The aim of this study was to understand the
role of vitamin D in chronic rhinosinusitis with nasal polyps (CRSwNP) by investigating its effect
on the secretion of matrix metalloproteinase-2 (MMP-2) and MMP-9 in nasal polyp-derived fi-
broblasts. Two primary fibroblast cultures were established from nasal polyp tissues obtained
during surgery. The nasal polyp-derived fibroblasts were stimulated with tumor necrosis factor-
a (TNF-a; 10 ng/mL) for 24 hours, followed by replacement with media alone or with vitamin D
derivatives (calcitriol or tacalcitol; 10mM) and incubated for another 24 hours. After the treat-
ments, the levels of MMP-2 and MMP-9 secreted were evaluated by both enzyme-linked immu-
nosorbent assay (ELISA) and Western blot analysis. ELISA results revealed that TNF-a could
substantially stimulate the secretion of MMP-2 (p < 0.01) and MMP-9 (p < 0.001) in nasaleclare no conflicts of interest.
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236 L.-F. Wang et al.polyp-derived fibroblasts. More importantly, such stimulatory effect was significantly sup-
pressed by adding calcitriol (p  0.01 for MMP-2 and p < 0.001 for MMP-9) or tacalcitol
(p < 0.005 for both MMP-2 and MMP-9). The ELISA results were also confirmed by Western blot
analysis. The inhibitory effect of vitamin D derivatives on MMP-2 and MMP-9 secretion could
potentiate their application in pharmacotherapy of Taiwanese CRSwNP patients.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Nasal polyposis (NP), a subgroup of chronic rhinosinusitis
(CRS), remains one of the most difficult challenges in clin-
ical rhinology. Although its etiology and pathophysiology
are still controversial, NP is believed to be the manifesta-
tion of complex inflammatory reactions [1]. At present,
topical steroids, which are generally safe and well toler-
ated, are the most commonly used therapeutic agents for
NP. Likewise, other forms of anti-inflammatory and anti-
proliferative agents are being intensively evaluated [2].
However, the results are still unsatisfactory, and, because
of frequent recurrence, repeated surgical interventions are
often necessary.
In addition to tissue eosinophilia, another important
histological characteristic of NP is tissue remodeling that
includes basement membrane thickening, gland modifica-
tions, extracellular matrix (ECM) accumulation, and
edema. These pathological changes are caused by secretion
of matrix metalloproteinases (MMPs) from epithelial cells,
fibroblasts, and infiltrating inflammatory cells [3,4]. MMPs,
a family of zinc- and calcium-dependent endopeptidases
that can collectively degrade almost all ECM components,
are key players in the process of airway remodeling. MMPs
produced by inflammatory cells are responsible for micro-
vascular permeability, leading to edema and cell trans-
migration, and ECM remodeling in asthmatic airways [5e7].
Many studies also have shown the occurrence of tissue
remodeling and the involvement of MMPs in the formation
of nasal polyps [8e10]. By contrast, fibroblasts, the major
structural components and physical barriers of airway mu-
cosa, have been shown to be critical in the complex
mechanism of polyp formation [1]. Stimulation of nasal fi-
broblasts might promote production of collagen and fibro-
nectin, resulting in abnormal ECM accumulation and tissue
remodeling in nasal polyps.
Vitamin D is known to regulate calcium and bone ho-
meostasis. However, increasing recent evidence has
revealed diverse physiological functions of vitamin D de-
rivatives, including immunomodulatory, antiproliferative,
and anti-inflammatory effects. Several studies have re-
ported the role of vitamin D in the pathogenesis and mani-
festation of airway diseases [11e13]. For example, vitamin D
deficiency is related to the severity of asthma and pulmonary
function [11,14e16]. Maternal vitamin D intake from foods
during pregnancy may be negatively associated with risk of
asthma and allergic rhinitis in childhood [17]. Furthermore,
in cultured cell models, vitamin D derivatives could inhibit
human nasal polyp-derived fibroblast proliferation [18], and
regulate Regulated on Activation, Normal T Cell Expressedand Secreted (RANTES) and interleukin-8 (IL-8) production in
normal human dermal fibroblasts and MMP-9 production in
keratinocytes [19,20]. Although there are several recent
reports indicating that vitamin D deficiency is correlated
with disease severity and might act as a key player in the
immunopathology of CRS with NP (CRSwNP) [21e23],
whether vitamin D could influence tissue remodeling of
CRSwNP by modulating secretion of MMPs is not clear and
warrants further investigation.
Materials and methods
Patients and tissues
The study was approved by the Institutional Review Board
of Kaohsiung Medical University Hospital (KMUH-IRB-
990427) and written informed consent was obtained from
each patient before study. Based on the definition in EP3OS
2007 [24], patients with the most recent diagnosis of
CRSwNP undergoing elective endoscopic sinus surgery at
our hospital were recruited. Patients with malignancies or
asthma were excluded from the study. All patients were
asked to stop any anti-inflammatory medications, including
antibiotics and topical steroids, for at least 2 weeks before
admission. Nasal polyp tissues were isolated from patients
with CRSwNP during operation.
Reagents and antibodies
Tumor necrosis factor-a (TNF-a) was purchased from Sigma
(H8916; St. Louis, MO, USA). Tacalcitol and calcitriol were
obtained from Tocris Bioscience (Ellisville, MO, USA).
Human MMP-2 and MMP-9 Quantikine ELISA kits were pur-
chased from R&D Systems (Minneapolis, MN, USA). Poly-
clonal MMP-2 and MMP-9 antibodies were from GeneTex
(Irvine, CA, USA).
Primary culture of nasal polyp-derived fibroblasts
The obtained tissues were washed three times with
antibiotics-containing Hank’s balanced salt solution (HBSS)
and cut into small pieces (1 mm3). The tissue explants were
treated with 0.5% trypsin for 7 minutes at 37C, followed by
neutralization with serum-containing Dulbecco’s modified
Eagle’s medium (DMEM). After washing three times with
HBSS, the explants were plated into 6-well culture dishes
(CellBIND Surface; Corning, Tewksbury, MA, USA) and
cultured with DMEM and 10% fetal bovine serum in a 37C,
5% CO2 humidified incubator for approximately 2 weeks.
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the nasal fibroblasts were subcultured into 10-cm dishes.
Nasal fibroblasts at the third to eighth passages were used
in the following experiments.
Enzyme-linked immunosorbent assay for MMP-2
and MMP-9
Nasal polyp-derived fibroblasts (5  104) were cultured in
each well of a 96-well plate with serum-containing or serum-
and TNF-a-containing (10 ng/mL) medium for 24 hours.
Subsequently, the medium of the TNF-a-treated group was
replaced with fresh serum-free medium alone or together
with calcitriol or tacalcitol (10mM), whereas the medium of
the mock-treated group was replaced with serum-free me-
dium. One day later, the concentrations of MMP-2 and MMP-9
secreted (pro- and active forms) in the culture supernatants
were determined by enzyme-linked immunosorbent assay
(ELISA; Human MMP-2 or MMP-9 Quantikine ELISA kit) based
on the manufacturer’s instructions. The optical density was
read at 450 nm using a microplate reader, and the concen-
trations were calculated by interpolation from a standard
curve. All measurements were performed in triplicate and
expressed as mean  standard deviation. The experiment
was repeated at least three times and the representative
data are shown in Figs. 1 and 2.
Western blot analysis of MMP-2 and MMP-9
Nasal fibroblasts (5  104) were seeded in each well of a 96-
well plate. After attachment for 3 hours, the cells were
treated exactly as mentioned earlier. The culture media
were collected and concentrated using a speed vacuum,
and the protein concentration was determined by bicin-
choninic acid assay. Eighty micrograms of each sample was
subjected to sodium dodecyl sulfateepolyacrylamide gel
electrophoresis. Afterward, the blots were probed withFigure 1. Inhibition of TNF-a-induced MMP-2 secretion by vitamin
Case No. 2) of primary culture were treated with TNF-a alone or TN
the culture media was measured using enzyme-linked immunosorb
decreased level of TNF-a-induced MMP-2 secretion. Each value i
triplicate). The experiment was repeated at least three times and t
statistical significance. MMP Z matrix metalloproteinase; SD Z stapolyclonal anti-MMP-2 or anti-MMP-9 antibodies (1:1000) at
4C overnight, followed by incubation with antirabbit
immunoglobulin G (1:20,000) at room temperature for 1
hour. The signals were visualized using enhanced chem-
iluminescence (SuperSignal, Pierce, Rockford, IL, USA) and
autoradiography. Quantification of the data was performed
using densitometry.
Statistical analysis
The results of ELISA were analyzed using one-way analysis
of variance (ANOVA) followed by least significant difference
(LSD) post hoc comparison of mock versus TNF-a, TNF-a
versus TNF-a þ calcitriol, and TNF-a versus TNF-
a þ tacalcitol, in which p < 0.05 was considered statisti-
cally significant.
Results
Vitamin D inhibited TNF-a-induced secretion of
MMP-2
To test our hypothesis that vitamin D might affect tissue
remodeling in nasal polyps by modulating MMPs production,
we examined whether calcitriol, an active form of vitamin
D, and tacalcitol, a vitamin D derivative, could inhibit MMPs
secretion in cultured nasal polyp fibroblasts. We estab-
lished two independent primary cultures of nasal polyp fi-
broblasts from two patients with CRSwNP. MMP-2 was first
induced by TNF-a for 24 hours, followed by the treatment
of calcitriol or tacalcitol for another 24 hours. The levels of
MMP-2 in culture media were measured using ELISA. One-
way ANOVA indicated significant difference among the
treatments (p Z 0.0014 for both cases). Further analysis
using LSD post hoc comparison revealed significant differ-
ence between mock and TNF-a (112.62  0.44 vs.
161.45  12.23 in Case No. 1, p < 0.001; 142.84  17.81 vs.D in nasal polyp-derived fibroblasts. Two cases (Case No. 1 and
F-a followed by calcitriol or tacalcitol. Secretion of MMP-2 into
ent assay. Addition of the vitamin D derivatives resulted in a
s the average  SD of three independent measurements (in
he representative data are shown. A p value < 0.05 represents
ndard deviation; TNF-a Z tumor necrosis factor-a.
Figure 2. Inhibition of TNF-a-induced MMP-9 secretion by vitamin D in nasal polyp-derived fibroblasts. Two cases (Case No. 1 and
Case No. 2) of primary culture were treated with TNF-a alone or TNF-a followed by calcitriol or tacalcitol. Secretion of MMP-9 into
the culture media was measured using enzyme-linked immunosorbent assay. Addition of the vitamin D derivatives resulted in a
decreased level of TNF-a-induced MMP-9 secretion. Each value is the average  SD of three independent measurements (in
triplicate). The experiment was repeated at least three times and the representative data are shown. A p value < 0.05 represents
statistical significance. MMP Z matrix metalloproteinase; SD Z standard deviation; TNF-a Z tumor necrosis factor-a.
Figure 3. Confirmation of the inhibitory effect of vitamin D
on MMP-2 and MMP-9 secretion. Nasal polyp-derived fibroblasts
were treated with TNF-a alone, or TNF-a followed by calcitriol
or tacalcitol, and the culture media were analyzed using
Western blot analysis using anti-MMP-2 or anti-MMP-9 anti-
bodies. Expression of both MMP-2 and MMP-9 was induced by
TNF-a (lane 2), but this was significantly inhibited by the
addition of vitamin D (lane 3 and 4). The numbers below the
blots are quantitative results of band intensities normalized to
the mock-treated control. The experiment was repeated four
times and the representative data are shown. MMP Z matrix
metalloproteinase; TNF-a Z tumor necrosis factor-a.
238 L.-F. Wang et al.232.60  13.73 in Case No. 2, p < 0.01). This TNF-a-induced
secretion of MMP-2 was significantly suppressed with the
addition of calcitriol (161.45  12.23 vs. 128.91  3.13 in
Case No. 1, p < 0.005; 232.60  13.73 vs. 179.23  20.57 in
Case No. 2, p Z 0.01) or tacalcitol (161.45  12.23 vs.
113.71  3.14 in Case No. 1, p < 0.001; 232.60  13.73 vs.
123.35  17.15 in Case No. 2, p < 0.005; Fig. 1).
Vitamin D inhibited TNF-a-induced secretion of
MMP-9
We next investigated how vitamin D would influence MMP-9
secretion in nasal polyp-derived fibroblasts using the same
approach. One-way ANOVA performed on the ELISA results
revealed significant difference among the treatments
(p Z 0.0001 in Case No. 1 and p Z 0.0005 in Case No. 2).
Analysis using post hoc comparison showed that, in both
primary cultures, MMP-9 was dramatically induced by TNF-a
(0.197  0.029 vs. 0.461  0.042 in Case No. 1, p < 0.001;
0.234  0.003 vs. 0.332  0.000 in Case No. 2, p < 0.001).
Such induction of MMP-9 was significantly suppressed in the
presence of calcitriol (0.461  0.042 vs. 0.300  0.043 in
Case No. 1, p < 0.001; 0.332  0.000 vs. 0.252  0.013 in
Case No. 2, p < 0.001) or tacalcitol (0.461  0.042 vs.
0.313  0.018 in Case No. 1, p < 0.001; 0.332  0.000 vs.
0.266  0.035 in Case No. 2, p < 0.005; Fig. 2). Together,
these results suggest that vitamin D can effectively inhibit
MMPs secretion in nasal polyp-derived fibroblasts.
Inhibitory effect of vitamin D on MMP-2 and MMP-9
secretion confirmed by Western blot analysis
To confirm the effect of vitamin D in the secretion of MMP-2
and MMP-9, nasal polyp-derived fibroblasts were treated as
aforementioned and the protein levels of MMP-2 and MMP-9
in culture media were examined using Western blot anal-
ysis. Consistent with the ELISA data, TNF-a-induced MMP-2and MMP-9 expression was significantly decreased in the
presence of calcitriol or tacalcitol. After repeating the
experiment four times, the representative data were
quantified and are shown in Fig. 3.
Discussion
NP remains one of the most challenging and refractory
diseases in clinical rhinology because of its undefined eti-
ology and predisposition to recurrence. Unfortunately, the
exact mechanism of NP pathogenesis is still unknown.
However, it is well established that MMPs are central to
tissue remodeling during nasal poly formation. It has been
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(25OHD) levels in CRSwNP patients were significantly lower
than those in CRS without NP patients [23]. Moreover, the
serum 25OHD level was significantly and inversely related
to the size of nasal polyps. Because vitamin D is believed to
have immunomodulatory effects on various immune cells
[25,26], these results thus suggest that low vitamin D levels
might fail to reduce cytokine release from inflammatory
cells, leading to constitutive activation of inflammatory
cascade.
A previous study demonstrated a significant dose-
dependent decrease in nasal polyp-derived fibroblast pro-
liferation when the cells were treated with various doses of
calcitriol and tacalcitol [18]. Rostkowska-Nadolska et al
[27] also indicated that calcitriol and tacalcitol inhibited
the synthesis of the proinflammatory cytokines IL-6 and IL-8
in nasal polyp fibroblast cultures. In this study, we hy-
pothesized that vitamin D would affect tissue remodeling of
NP by regulating the production of MMPs. TNF-a is a cyto-
kine with a wide spectrum of proinflammatory functions. In
addition, MMPs are known to be associated with airway and
pulmonary inflammation [28e31]. Thus, we used TNF-a to
induce the production of MMPs and tested whether such
induction could be inhibited by vitamin D treatment in two
independent primary cultures of nasal polyp-derived fibro-
blasts. Indeed, our ELISA results demonstrated that TNF-a
could significantly induce the secretion of MMP-2 and MMP-9
from the cells, and this biological effect was significantly
suppressed by the addition of calcitriol and tacalcitol. It is
noticeable that tacalcitol had a better inhibitory effect
than calcitriol against TNF-a-induced MMP-2, which was
also confirmed by Western blot analysis. However, the
mechanism behind the suppression of these MMPs secretion
by vitamin D is currently unclear. Whether vitamin D could
block intracellular MMPs production, either at the tran-
scriptional or translational level, or the release process of
MMPs into the media deserves further study. Given that the
expression of MMPs promotes inflammatory and immune
responses in multiple cell contexts [28e31], the anti-
inflammation effect of vitamin D might be mediated
through inhibition of MMPs in nasal polyps. A more detailed
study is ongoing.
Our findings suggest that in patients with vitamin D
deficiency, low vitamin D level might be insufficient to
counter the secretion of MMPs, leading to chronic inflam-
mation and ECM remodeling which are two major charac-
teristics in the pathophysiology of NP. However, there are
limitations in the present study. For example, the in vitro
cell model might not completely reflect in vivo mecha-
nisms. However, we thought that nasal polyp-derived fi-
broblasts are a legitimate cell model for this study for three
reasons: (1) fibroblasts are an important component of the
ground substances in nasal polyps and are involved in a
variety of inflammatory responses associated with the dis-
ease pathogenesis [1]; (2) fibroblasts are one of the major
stromal cells that produce and secrete MMPs; and (3)
several published studies had used nasal polyp-derived fi-
broblasts as the cell model for tissue remodeling mecha-
nisms and therapeutic applications in NP [32,33].
In conclusion, this is the first study to investigate the
effect of vitamin D on the in vitro secretion of MMP-2 and
MMP-9 in nasal polyp-derived fibroblasts. We showed thatvitamin D derivatives could significantly inhibit TNF-a-
induced MMP-2 and MMP-9 secretion in nasal polyp-derived
fibroblasts. These results may not only shed light on the
mechanism of NP pathogenesis, but also warrant further
investigation for the clinical application of vitamin D in
pharmacotherapy of NP.Acknowledgments
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